THERAPEUTIC PRODUCTIONS CIC

Company limited by guarantee

Company Registration Number:
14576167 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2024

Period of accounts

Start date: 6 January 2023

End date: 31 January 2024

THERAPEUTIC PRODUCTIONS CIC

Contents of the Financial Statements

for the Period Ended 31 January 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

THERAPEUTIC PRODUCTIONS CIC

Profit And Loss Account

for the Period Ended 31 January 2024

13 months to 31 January 2024


£
Turnover: 35,500
Cost of sales: 0
Gross profit(or loss): 35,500
Distribution costs: 0
Administrative expenses: ( 2,000 )
Operating profit(or loss): 33,500
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 33,500
Tax: 0
Profit(or loss) for the financial year: 33,500

THERAPEUTIC PRODUCTIONS CIC

Balance sheet

As at 31 January 2024

Notes 13 months to 31 January 2024


£
Fixed assets
Intangible assets:   0
Tangible assets: 3 1,000
Investments:   0
Total fixed assets: 1,000
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 8,005
Investments:   0
Total current assets: 8,005
Prepayments and accrued income: 500
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 8,505
Total assets less current liabilities: 9,505
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 9,505
Members' funds
Profit and loss account: 9,505
Total members' funds: 9,505

The notes form part of these financial statements

THERAPEUTIC PRODUCTIONS CIC

Balance sheet statements

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 February 2024
and signed on behalf of the board by:

Name: Jerome Sewell
Status: Director

The notes form part of these financial statements

THERAPEUTIC PRODUCTIONS CIC

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

THERAPEUTIC PRODUCTIONS CIC

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Employees

    13 months to 31 January 2024
    Average number of employees during the period 1

THERAPEUTIC PRODUCTIONS CIC

Notes to the Financial Statements

for the Period Ended 31 January 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 1,000 1,000
Disposals
Revaluations
Transfers
At 31 January 2024 1,000 1,000
Depreciation
Charge for year
On disposals
Other adjustments
At 31 January 2024
Net book value
At 31 January 2024 1,000 1,000

COMMUNITY INTEREST ANNUAL REPORT

THERAPEUTIC PRODUCTIONS CIC

Company Number: 14576167 (England and Wales)

Year Ending: 31 January 2024

Company activities and impact

In that financial year we have worked with 40 people including those with mental health difficulties at psychiatric hospitals and ex offenders.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

7435

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
1 February 2024

And signed on behalf of the board by:
Name: Jerome Sewell
Status: Director